Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Clinical trial NCT04598009 · RECRUITING
Trial details
- NCT number
- NCT04598009
- Sponsor
- University of California, San Francisco
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-03
- Primary completion
- 2027-05-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.